Kroger health establishes clinical trial site network to increase reach and access to research studies

Announcement comes with the collaboration with biopharmaceutical industry to introduce colorectal cancer clinical trial cincinnati , jan. 24, 2023 /prnewswire/ -- kroger health, the healthcare division of the kroger co. (nyse: kr), today announced the establishment of its clinical trial site network in conjunction with pharmaceutical industry sponsors, contract research organizations, and health systems. the announcement comes with kroger's first trial in active recruitment for colorectal cancer gut and immune health observation.
KR Ratings Summary
KR Quant Ranking